Prognostic role of clinical presentation in symptomatic patients with hypertrophic cardiomyopathy
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
AIMS: To evaluate the long-term prognostic impact of baseline symptoms in a cohort of hypertrophic cardiomyopathy (HCM) patients. METHODS AND RESULTS: We considered 84 HCM patients symptomatic at diagnosis: 26 (31%) with heart failure (group 1), 34 (40%) with syncope/palpitations (group 2) and 24 (29%) with chest pain (group 3). During a median follow-up of 102 (53-187) months, 25 (30%) patients died/underwent heart transplant (HTx), 14 of 26 (54%) in group 1, 10 of 34 (29%) in group 2 and one of 24 (4%) in group 3. At 12, 60 and 120 months, HTx-free survival rates were 100, 79 and 52% in group 1, vs. 100, 97 and 69% in group 2, vs. 96, 96 and 96% in group 3, respectively (P = 0.008). At multivariate analysis, heart failure [hazard ratio (HR) 2.59, confidence interval (CI) 95% 1.09-6.17, P = 0.032] and left atrium diameter (HR 1.83, CI 95% 1.16-2.89, P = 0.009) emerged as independent predictors of death/HTx, with incremental prognostic power with respect to echo Doppler variables of left ventricular systolic and diastolic dysfunction [area under the curve (AUC) of receiver operating characteristics (ROC) curves at 5 years: 0.90 vs. 0.78, respectively, P = 0.03]. CONCLUSION: Clinical presentation emerged as a relevant prognostic tool in HCM patients symptomatic at onset, as heart failure was associated with a particularly poor outcome. Heart failure and left atrium diameter at diagnosis showed incremental prognostic power compared with echo Doppler assessment of left ventricular systolic and diastolic dysfunction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
Heagerty, P. J., Lumley, T., & Pepe, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,854
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., Ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,578
Appleton, C. P., Hatle, L. K., & Popp, R. L. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90416-0 · Cited by 1,568
Nishimura, R. A., & Tajik, A. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00144-7 · Cited by 1,251
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Priori, S. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2824 · Cited by 903
Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 804
Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy
Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025050 · Cited by 782
Harris, K. M., Spirito, P., Maron, M. S., Zenovich, A. G., Formisano, F., Lesser, J. R., Mackey-Bojack, S., Manning, W. J., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.105.583500 · Cited by 671
Nagueh, S. F., Lakkis, N. M., Middleton, K. J., Spencer, W. H., Zoghbi, W. A., & Quiñones, M. A. (1999) · Circulation · doi:10.1161/01.cir.99.2.254 · Cited by 530
Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients.
Maron, B. J., Roberts, W. C., & Epstein, S. E. (1982) · Circulation · doi:10.1161/01.cir.65.7.1388 · Cited by 520
Maron, B. J., Bonow, R. O., Cannon, R. O., Leon, M. B., & Epstein, S. E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704023161405 · Cited by 370
Maron, B. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01282-8 · Cited by 370
Clinical Course and Prognosis of Hypertrophic Cardiomyopathy in an Outpatient Population
Spirito, P., Chiarella, F., Carratino, L., Berisso, M. Z., Bellotti, P., & Vecchio, C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903233201201 · Cited by 326
Geske, J. B., Sorajja, P., Nishimura, R. A., & Ommen, S. R. (2007) · Circulation · doi:10.1161/circulationaha.107.698985 · Cited by 325
Natural History of Hypertrophic Cardiomyopathy: A Population-Based Study, 1976 Through 1990
Cannan, C. R., Reeder, G. S., Bailey, K. R., Melton, L. J., & Gersh, B. J. (1995) · Circulation · doi:10.1161/01.cir.92.9.2488 · Cited by 264
Yoerger, D. M., Marcus, F., Sherrill, D., Calkins, H., Towbin, J. A., Zareba, W., & Picard, M. H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.070 · Cited by 252
Nistri, S., Olivotto, I., Betocchi, S., Losi, M. A., Valsecchi, G., Pinamonti, B., Conte, M. R., Casazza, F., Galderisi, M., Maron, B. J., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.05.013 · Cited by 251
Self-citationClinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy
Melacini, P., Basso, C., Angelini, A., Calore, C., Bobbo, F., Tokajuk, B., Bellini, N., Smaniotto, G., Zucchetto, M., Iliceto, S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq136 · Cited by 230
Kofflard, M. J. M., Ten Cate, F. J., van der Lee, C., & van Domburg, R. T. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)03004-8 · Cited by 220
Phenotypic diversity in hypertrophic cardiomyopathy
Arad, M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2499 · Cited by 183
Management of Symptoms in Hypertrophic Cardiomyopathy
Fifer, M. A., & Vlahakes, G. J. (2008) · Circulation · doi:10.1161/circulationaha.107.694158 · Cited by 144
Outcome of Mildly Symptomatic or Asymptomatic Obstructive Hypertrophic Cardiomyopathy
Sorajja, P., Nishimura, R. A., Gersh, B. J., Dearani, J. A., Hodge, D. O., Wiste, H. J., & Ommen, S. R. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.079 · Cited by 136
Spirito, P., & Maron, B. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90278-w · Cited by 127
Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy
Biagini, E., Spirito, P., Rocchi, G., Ferlito, M., Rosmini, S., Lai, F., Lorenzini, M., Terzi, F., Bacchi-Reggiani, L., Boriani, G., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.07.057 · Cited by 115
Echocardiographic and Doppler Assessment of Hypertrophic Cardiomyopathy
Rakowski, H., Sasson, Z., & Wigle, E. D. (1988) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(88)80062-2 · Cited by 90
Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy
Takagi, E., Yamakado, T., & Nakano, T. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00555-5 · Cited by 83
Shapiro, L. M., & Zezulka, A. V. (1983) · Heart · doi:10.1136/hrt.50.6.530 · Cited by 68
Badano, L. P., Pezzutto, N., Marinigh, R., Cinello, M., Nucifora, G., Pavoni, D., Gianfagna, P., & Fioretti, P. M. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3282f194f0 · Cited by 64
Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future
Ommen, S. R., Shah, P. M., & Tajik, A. J. (2008) · Heart · doi:10.1136/hrt.2008.154435 · Cited by 63
The Italian registry for hypertrophic cardiomyopathy: A nationwide survey
Cecchi, F., Olivotto, I., Betocchi, S., Rapezzi, C., Conte, M. R., Sinagra, G., Zachara, E., Gavazzi, A., Rordorf, R., Carnemolla, G., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.01.005 · Cited by 60
Self-citationScreening for hypertrophic cardiomyopathy in a young male military population
Nistri, S., Thiene, G., Basso, C., Corrado, D., Vitolo, A., & Maron, B. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00132-2 · Cited by 55
Pinamonti, B., Merlo, M., Nangah, R., Korcova, R., Lenarda, A. D., Barbati, G., & Sinagra, G. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283383355 · Cited by 22
Self-citationTimmer, S. A. J., Germans, T., Götte, M., Rüssel, I. K., Lubberink, M., ten Berg, J. M., ten Cate, F. J., Lammertsma, A. A., Knaapen, P., & van Rossum, A. C. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.01.029 · Cited by 18
Innelli, P., Galderisi, M., Catalano, L., Martorelli, M. C., Olibet, M., Pardo, M., Rotoli, B., & DIVITIIS, O. D. (2006) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000247321.49912.23 · Cited by 10
Research works printed but not linked: 3
- 1964, BMJ, 18, 177
- Maron, 2007, JAMA, 298, 405
- Maron, 2002, JAMA, 287, 1308
Cited by
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303
“As syncope is considered a risk factor for SCD in patients with HCM, careful workup including ECG, exercise test, and AECG should be performed.”
BackgroundInfluentialSteinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P. F., Balsam, P., Baranchuk, A. M., Cantillon, D. J., Dilaveris, P., Dubner, S., El‐Sherif, N., et al. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12447 · Cited by 131
“As syncope is considered a risk factor for SCD in patients with HCM, careful workup including ECG, exercise test, and AECG should be performed.”
BackgroundInfluentialCrotti, L., Brugada, P., Calkins, H. G., Chevalier, P., Conte, G., Finocchiaro, G., Postema, P. G., Probst, V., Schwartz, P. J., & Behr, E. R. (2023) · EP Europace · doi:10.1093/europace/euad180 · Cited by 68
“Dilated cardiomyopathy is a severe and misunderstood disease that affect millions of young patients worldwide.123 Its complex and diverse clinical phenotype stems from dynamic interactions between multiple genetic and non-genetic factors and explains the substantial differences in DCM penetrance.5 Family screening is…”
InfluentialSelf-citationSurvival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis
Liu, Q., Li, D., Berger, A. E., Johns, R. A., & Gao, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-12289-4 · Cited by 66
Negri, F., Muser, D., Driussi, M., Sanna, G. D., Masè, M., Cittar, M., Poli, S., Bellis, A. D., Fabris, E., Puppato, M., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.10.148 · Cited by 54
Self-citation
Metadata
- Authors
- Finocchiaro, G., Pinamonti, B., Merlo, M., Brun, F., Barbati, G., & Sinagra, G.
- Affiliations
- University of Trieste (IT)
- Corresponding author
- Finocchiaro, Gherardo
- Venue
- Journal of Cardiovascular Medicine
- Published
- 2012-12
- Volume
- 13
- Issue
- 12
- Pages
- 810-818
- ISSN
- 1558-2027 (ISSN-L)
- OpenAlex
- W2028181015
- Cited by
- 12
- References
- 37
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2018: 1 · 2017: 3 · 2014: 4
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cardiovascular Medicine (publishedVersion)
- PubMed (publishedVersion)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Keywords
- hypertrophic cardiomyopathy, prognosis, clinical features, heart failure, syncope, palpitations, chest pain, left atrial diameter, heart transplantation, mortality, left ventricular systolic dysfunction, left ventricular diastolic dysfunction, Doppler echocardiography
- MeSH terms
- Adolescent, Adult, Aged, Arrhythmias, Cardiac, Cardiomyopathy, Hypertrophic, Cardiovascular Agents, Chest Pain, Child, Child, Preschool, Female, Heart Atria, Heart Failure, Humans, Infant, Italy, Male, Middle Aged, Predictive Value of Tests, Prognosis, Registries, Risk Factors, Syncope, Time Factors, Echocardiography, Doppler, Multivariate Analysis, Chi-Square Distribution, Proportional Hazards Models, Heart Transplantation, Ventricular Function, Left, Disease-Free Survival, Kaplan-Meier Estimate, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.